Skip to main content
    S

    Sotera Health Co (SHC)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $16.05
    -0.20 (-1.23%)

    Market Cap: $4.74B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Sotera Health Co (SHC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Sotera Health (SHC) has a market cap of $4.74B and an enterprise value of $6.60B. Its return on invested capital of 8.96% compares with a 2.74% median across 7 similar companies.

    Total Valuation

    Enterprise value is 39.21% above the market cap, as debt exceeds cash.

    Market Cap$4.74B
    Enterprise Value$6.60B
    Latest price (Nov 17, 2026)$16.05

    Key Dates

    The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 22, 2027 (expected)
    Last Earnings DateNov 3, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.08% in the quarter ended Sep 30, 2026 and grew 0.52% a year over 2 years.

    Shares Outstanding286.00M
    Shares Change (YoY)+0.68%
    Shares Change (QoQ)+0.08%
    Share Count Growth (2Y CAGR)+0.52%

    Valuation Ratios

    Sales and book value multiples are 3.7x and 6.3x. Its year-end P/E ranged from 8.6x to 227.0x from 2020 to 2025.

    P/E Ratio16.9x
    Forward P/E16.2x
    P/S Ratio3.7x
    Forward P/S3.8x
    P/B Ratio6.3x
    P/FCF Ratio33.9x
    P/OCF Ratio14.3x
    PEG Ratio1.6

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 11.7x EBITDA and 47.6x free cash flow.

    EV / Earnings38.1x
    EV / Sales5.4x
    EV / EBITDA11.7x
    EV / EBIT15.9x
    EV / FCF47.6x

    Price Statistics

    The stock is up 2.62% over 52 weeks and trades 10.13% below its 50-day average.

    Beta (1Y)0.98
    52-Week Change+2.62%
    1-Month Change-9.01%
    3-Month Change-15.53%
    6-Month Change+5.38%
    5-Year Change-26.52%
    Total Return (1Y)+2.62%
    Total Return (3Y CAGR)+5.53%
    Total Return (5Y CAGR)-6.60%
    Return vs SPY (1Y)-6.17%
    Max Drawdown (1Y)-32.14%
    Max Drawdown (3Y)-43.48%
    Sharpe Ratio (1Y)0.17
    Correlation with SPY (1Y)0.45
    50-Day Average$17.86
    200-Day Average$16.87
    52-Week Range$13.09 to $19.85
    RSI (14 Days)36.4
    Average Volume (20 Days)2.82M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.13x current liabilities, and total debt is 3.10x shareholder equity.

    Current Ratio3.13x
    Quick Ratio2.91x
    Debt / Equity3.10x
    Debt / EBITDA4.13x
    Debt / FCF16.78x
    Interest Coverage208.41x

    Returns and Efficiency

    Return on invested capital is 8.96% over the last 12 months, against a 5-year average of 7.76%.

    Return on Equity (ROE)23.66%
    Return on Assets (ROA)5.12%
    Return on Invested Capital (ROIC)8.96%
    Return on Capital Employed (ROCE)13.10%
    ROE (5Y Average)-10.36%
    ROA (5Y Average)-0.47%
    ROIC (5Y Average)7.76%
    Asset Turnover0.37x
    Inventory Turnover10.53x
    Receivables Turnover8.11x
    Cash Conversion Cycle21 days

    Taxes

    Income tax took 36.90% of pretax income over the last 12 months.

    Income Tax (TTM)$101.42M
    Effective Tax Rate36.90%

    Scores

    SHC has an Altman Z-Score of 1.81, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score1.81
    Altman Z ZoneGrey
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.23B over the last 12 months is up 6.90% from the 12 months before.

    Revenue$1.23B
    Revenue Growth (YoY)+6.90%
    Gross Profit$671.74M
    Operating Income$466.59M
    Pretax Income$274.89M
    Net Income$173.47M
    EBITDA$549.81M
    EBIT$414.44M
    Reported EPS (TTM)$0.95

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 21.63% of the $3.39B in total assets.

    Cash and Equivalents$412.38M
    Total Debt$2.27B
    Net Debt$1.86B
    Net Debt Per Share$6.50
    Working Capital$477.34M
    Shareholder Equity$733.24M
    Book Value Per Share$2.56
    Tangible Book Value-$622.81M
    Total Assets$3.39B
    Total Liabilities$2.65B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $196.15M of capital spending, operating cash flow left $135.43M of free cash flow.

    Operating Cash Flow$331.58M
    Capital Expenditures$196.15M
    Free Cash Flow$135.43M
    FCF Per Share$0.47
    Depreciation and Amortization$135.36M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 37.94%.

    Gross Margin54.62%
    Operating Margin37.94%
    Pretax Margin22.35%
    Net Margin14.11%
    EBITDA Margin44.71%
    EBIT Margin33.70%
    FCF Margin11.01%

    Growth

    Revenue Growth (5Y CAGR)+7.30%
    EPS Growth (3Y CAGR)-3.93%
    EPS Growth (5Y CAGR)+48.05%
    FCF Growth (3Y CAGR)+16.00%
    FCF Growth (5Y CAGR)+17.33%
    Operating Income Growth (3Y CAGR)+13.39%
    Book Value Per Share Growth (2Y CAGR)+16.24%

    Revenue and profit by year

    Dividends and Yields

    SHC does not pay a dividend. Its free cash flow yield is 2.95%.

    Earnings Yield5.92%
    FCF Yield2.95%
    Shareholder Yield0.00%

    Peer Position

    Against 8 similar companies, SHC has the 8th highest P/E.

    P/E Ratio16.9x vs 33.8x median
    P/S Ratio3.7x vs 4.8x median
    ROIC8.96% vs 2.74% median
    Revenue Growth (Trailing 4 Quarters, YoY)+6.90% vs +17.18% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 6.19% and EPS growth at 11.28% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+6.19%
    EPS Growth Forecast (2Y CAGR)+11.28%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SHC

    What is SHC's market cap?

    Sotera Health has a market cap of $4.74B. Its enterprise value, which adds debt and subtracts cash, is $6.60B.

    What is SHC's P/E ratio?

    Sotera Health has a trailing P/E ratio of 16.9x and a forward P/E of 16.2x.

    How many shares of SHC are outstanding?

    Sotera Health has 286.00M shares outstanding. The count is up 0.68% from a year earlier.

    Does SHC pay a dividend?

    No. Sotera Health does not pay a dividend.

    How much debt does SHC have?

    Sotera Health has $2.27B of total debt and $412.38M of cash and equivalents, a net debt position of $1.86B.